Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist-Reference-Cited by-同舟云学术

Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist

Published:2016-10 Issue:43 Volume:291 Page:22460-22471
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Makita Noriko,Sato Tomohiko,Yajima-Shoji Yuki,Sato Junichiro,Manaka Katsunori,Eda-Hashimoto Makiko,Ootaki Masanori,Matsumoto Naoki,Nangaku Masaomi,Iiri Taroh

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference35 articles.

1. Nephrogenic diabetes insipidus;Bichet;Adv. Chronic Kidney Dis,2006

2. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus;Robben;Am. J. Physiol. Renal Physiol,2006

3. Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature;Neocleous;Metabolism,2012

4. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus;Bockenhauer;Nat. Rev. Nephrol,2015

5. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants;Morello;J. Clin. Invest,2000

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of YM087 and VPA985 on the T237M mutant receptor functionality in nephrogenic diabetes insipidus;Turkish Journal of Biochemistry;2024-08-20

2. Therapeutic potentials of nonpeptidic V2R agonists for partial cNDI-causing V2R mutants;PLOS ONE;2024-05-15

3. Pharmacological Chaperones;Protein Homeostasis in Drug Discovery;2022-11-14

4. Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused by biased allosteric CaSR autoantibodies;JCI Insight;2022-10-24

5. Functional Rescue of a Nephrogenic Diabetes Insipidus Causing Mutation in the V2 Vasopressin Receptor by Specific Antagonist and Agonist Pharmacochaperones;Frontiers in Pharmacology;2022-01-25